Trial Profile
A RANDOMIZED, MULTICENTRE PHASE IIa OPEN-LABEL, ACTIVE-COMPARATOR TRIAL TO ASSESS THE EFFICACY AND SAFETY OF TWO REGIMENS OF BUCILLAMINE 100 MG TABLETS AS COMPARED TO COLCHICINE 0.6 MG TABLETS FOR THE TREATMENT OF AN ACUTE GOUT FLARE IN SUBJECTS WITH MODERATE TO SEVERE GOUT
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2016
Price :
$35
*
At a glance
- Drugs Bucillamine (Primary) ; Colchicine
- Indications Gout
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Sponsors Revive Therapeutics
- 01 Dec 2015 Status changed from active, no longer recruiting to completed, based on the information provided in a Revive Therapeutics media release.
- 01 Dec 2015 Results published in the Revive Therapeutics Media Release
- 29 Oct 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.